Results 121 to 130 of about 1,107,385 (201)

Polypharmacy in Elderly Patients Receiving First-Line Treatment for Pancreatic Adenocarcinoma: Analysis of Potential Drug-Drug Interactions and Outcome. [PDF]

Oncol Res
Vecchia S, Chinelli R, Orcesi A, Citterio C, Riva A, Orlandi E.   +5 more
europepmc   +1 more source

Coupled pharmacokinetic model unveils drug-drug interactions in plasma concentration. [PDF]

PLoS One
Huang H, Li C, Chen Q, Zhuang C, Yu L, Jin W, Li X.   +6 more
europepmc   +1 more source

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML. [PDF]

Antimicrob Agents Chemother
Joisten CS, Mellinghoff SC, Seidel D, Müller C, Müller-Ohrem C, Kreuzer K-A, Frenzel LP, Simon F, Hallek M, Koehler P, Cornely OA, Stemler J.   +11 more
europepmc   +1 more source

Patterns and determinants of drug-drug interactions among community-dwelling older adults in Saudi Arabia: a cross-sectional study. [PDF]

Front Pharmacol
Khawagi WY, Aldali JA, Aljohani RM, Alshehri AA.   +3 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]

Int J Mol Sci
Hirai T, Katayama K.
europepmc   +1 more source

An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in Rat. [PDF]

Drug Des Devel Ther
Li H, Wu H, Gao S, Cui L, Xu J, Sun J, Liu Z, Wang Z, Tao X.   +8 more
europepmc   +1 more source

Prediction of the Pharmacokinetic Drug Interactions of Direct Oral Anticoagulants Using Mechanistic Static Modelling

Background Direct oral anticoagulants are cardiovascular drugs used in the clinical treatment and prevention of thromboembolism. Pharmacokinetic drug interactions may cause a decrease or several-fold increases in their exposure leading to unfavourable ...
Schaat, Mostafa
core  

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors. [PDF]

Expert Rev Clin Pharmacol
Stromatt JC, Chowdhury AT, Huang KM, Hu S, Sparreboom A, Baker SD, Eisenmann ED.   +6 more
europepmc   +1 more source

High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study. [PDF]

Ann Med
Ma J, Chen H, Guo C, He G, Yang G.
europepmc   +1 more source

Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug-Drug Interactions of Flumatinib as Both a Victim and a Perpetrator. [PDF]

Drug Des Devel Ther
Alifu M, Chu X, Zhu X, Mak WY, Zheng A, Pan C, He Q, Zhu X, Kuai Z, Xiang X.   +9 more
europepmc   +1 more source